Gene therapy for progressive familial intrahepatic cholestasis type 3 in a clinically relevant mouse model

Journal: Nature Communications

Published: 2019-12-13

DOI: 10.1038/s41467-019-13614-3

Affiliations: 4

Authors: 8

Go to article
Institutions Share
Vivet Therapeutics SAS, France 0.38
University of Navarra (UNAV), Spain 0.35
Vivet Therapeutics S.L., Spain 0.17
Healthcare Research Institute of Navarre (IdiSNA), Spain 0.10